Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study
Laura Dormer, Co-Founder and Editorial Director at Becaris Publishing, shared on LinkedIn about a recent article by Benoit Polack et al, adding:
”New Research Article published in the Journal of Comparative Effectiveness Research
‘Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study’
Using the French national healthcare claims database, the FORvWARD study examines treatment patterns, healthcare resource use and associated costs among adults with von Willebrand disease using on-demand replacement therapies.
This real-world analysis offers valuable insight into resource use in a rare bleeding disorder and highlights the role of national claims data in comparative treatment evaluation.”
Title: Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study
Authors: Benoit Polack, Virginie Nerich, Claire Marant Micallef, Marc Trossaërt, Christine Biron-Andreani, Nadège Bornier, Catherine Chatelanaz, Franck Favre-Besse, Julien Beoletto, Mélanie Née, Manon Belhassen, Cinira Lefèvre, Gérard de Pouvourville
Read the Full Article on Journal of Comparative Effectiveness Research
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 15, 2026, 19:41Looking Beyond Platelet Counts to Quality of Life in ITP – American Society of Hematology
-
Oct 15, 2026, 19:32Markus Gregorio Barbosa: Hepatic VPS35 and Cholesterol Homeostasis
-
Oct 15, 2026, 19:18Emerging Novel Therapies for Hereditary Hemorrhagic Telangiectasia – The Lancet Haematology
-
Oct 15, 2026, 19:04Umberto Pensato: EVT Treatment Effects Across Perfusion Profiles in MeVO Stroke
-
Oct 15, 2026, 18:26Chanakya Nayudu: Presenting My Research at ISTH Congress 2026 in Paris
-
Oct 15, 2026, 18:09Maha Othman: Students Lead World Thrombosis Day 2026 Awareness Events
-
Oct 15, 2026, 17:52Jill de Mol։ Rapamycin Modulates Immune Responses in Aged Atherosclerosis
-
Oct 15, 2026, 17:41Victor Aboyans։ Think About Lipids in VTE
-
Oct 15, 2026, 17:08Babu Mia։ Targeting PPM1D to Eliminate Malignant Stem Cells in Myeloproliferative Neoplasms